KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scotts Miracle-Gro (SMG) Cash & Equivalents (2016 - 2025)

Scotts Miracle-Gro (SMG) has disclosed Cash & Equivalents for 17 consecutive years, with $8.3 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 45.61% to $8.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.3 million through Dec 2025, up 45.61% year-over-year, with the annual reading at $32.8 million for FY2025, 54.19% down from the prior year.
  • Cash & Equivalents hit $8.3 million in Q4 2025 for Scotts Miracle-Gro, down from $32.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $279.9 million in Q2 2024 to a low of $5.7 million in Q4 2024.
  • Historically, Cash & Equivalents has averaged $54.2 million across 5 years, with a median of $27.4 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 1370.48% in 2021 and later plummeted 81.74% in 2025.
  • Year by year, Cash & Equivalents stood at $244.1 million in 2021, then plummeted by 89.51% to $25.6 million in 2022, then crashed by 59.38% to $10.4 million in 2023, then plummeted by 45.19% to $5.7 million in 2024, then soared by 45.61% to $8.3 million in 2025.
  • Business Quant data shows Cash & Equivalents for SMG at $8.3 million in Q4 2025, $32.8 million in Q3 2025, and $51.1 million in Q2 2025.